» Vaccine-preventable infections

Devices for preventing percutaneous exposure injuries caused by needles in healthcare personnel

Read the full article
A Cochrane review of medical devices designed to reduce the risk of virus transmission through percutaneuous exposure injuries caused by needles.

Full Story »

Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola Virus Disease

Read the full article
This new review compares the different ways to give fluids to people in situations where it is impossible to maintain adequate hydration simply by giving fluids orally. Collectively, these alternatives are termed parenteral access. They include getting fluids into a vein (intravenously), …

Full Story »

The Effectiveness of Disaster Risk Communication: A Systematic Review of Intervention Studies

Read the full article
A review of communication interventions relevant to disasters, including infection outbreaks. Interventions associated with increased knowledge of preventive measures include individual and group face-to-face information sessions, telephone calls, delivery of written information, mass media campaigns, mass SMS text messages and games for …

Full Story »

Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age

Read the full article
There is some evidence to support the effectiveness of preventative zinc supplementation particularly, where the risk of zinc deficiency is high. However, more evidence on optimal intervention characteristics such as supplement dose is needed.
Zinc deficiency is responsible for significant morbidity and mortality …

Full Story »

Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age

Read the full review here
There is insufficient evidence from clinical trials on the effectiveness (efficacy and safety) of antibiotics in reducing the risk of otitis or pneumonia in children aged between two and 59 months with undifferentiated acute respiratory infections (ARIs).
ARIs are a group of …

Full Story »

Ebola virus disease: Key questions and answers concerning water, sanitation and hygiene

Ebola Virus Disease (EVD): Key Questions and Answers Concerning Water, Sanitation and Hygiene (WHO 2014): Controlling the hazards from the presence of the Ebola virus in body fluids lies in the separation and containment of all body fluids (including feces and urine). Feces from suspected …

Full Story »

Intermittent versus daily therapy for treating tuberculosis in children

Read the full article
Evidence from four randomised trials was insufficient to determine that the use of daily drug treatment was more effective than intermittent (twice- or thrice-weekly) treatment for children with tuberculosis.
Childhood tuberculosis is a neglected global public health problem. Rifampicin-containing drugs given daily for …

Full Story »

Routine vitamin A supplementation for the prevention of blindness due to measles infection in children

Read the full review here
No evidence was found to investigate whether vitamin A can prevent blindness in children infected with measles.
Annually 500,000 children become blind worldwide, 75% of them living in low-income countries. Measles infection in children has been associated with vitamin A deficiency and …

Full Story »

Physical interventions to interrupt or reduce the spread of respiratory viruses

Read full article
There is some evidence to suggest that some low cost and simple interventions such as hand washing would be useful in helping to reduce the transmission of epidemic respiratory viruses. Implementing transmission barriers, isolation and hygienic measures are effective at containing respiratory virus …

Full Story »

Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age

Read full article
There is insufficient evidence from randomised controlled trials (RCTs) to support the use of zinc as an adjunct to antibiotics in the treatment of pneumonia in children aged between 2 and 59 months.
Acute respiratory infections particularly pneumonia, are responsible for high mortality in …

Full Story »